Search Results - "MEYERS, ABBY"

Triglyceride Paradox Is Related to Lipoprotein Size, Visceral Adiposity and Stearoyl-CoA Desaturase Activity in Black Versus White Women by Chung, Stephanie T., Cravalho, Celeste K.L., Meyers, Abby G., Courville, Amber B., Yang, Shanna, Matthan, Nirupa Rachel, Mabundo, Lilian, Sampson, Maureen, Ouwerkerk, Ronald, Gharib, Ahmed M., Lichtenstein, Alice H., Remaley, Alan T., Sumner, Anne E.

“…In black women, triglycerides are paradoxically normal in the presence of insulin resistance. This relationship may be explained by race-related differences in…”
Get full text

226-OR: The Lipoprotein Insulin Resistance Index Is a Measure of Hepatic and Total Insulin Resistance: The Federal Women's Study by CRAVALHO, CELESTE K., MEYERS, ABBY G., MABUNDO, LILIAN, SUMNER, ANNE E., CHUNG, STEPHANIE T.

“…The lipoprotein insulin resistance index (LPIR) is an emerging biomarker that correlates with peripheral insulin resistance (IR) derived from a composite score…”
Get full text

Metformin improves blood glucose by increasing incretins independent of changes in gluconeogenesis in youth with type 2 diabetes by Cravalho, Celeste K. L., Meyers, Abby G., Mabundo, Lilian S., Courville, Amber, Yang, Shanna, Cai, Hongyi, Dai, Yuhai, Walter, Mary, Walter, Peter J., Sharma, Susan, Chacko, Shaji, Cogen, Fran, Magge, Sheela N., Haymond, Morey W., Chung, Stephanie T.

“…Aims/hypothesis Metformin is the only approved oral agent for youth with type 2 diabetes but its mechanism of action remains controversial. Recent data in…”
Get full text

The effects of prebiotics on gastrointestinal side effects of metformin in youth: A pilot randomized control trial in youth-onset type 2 diabetes by Dixon, Sydney A, Mishra, Sidharth, Dietsche, Katrina B, Jain, Shalini, Mabundo, Lilian, Stagliano, Michael, Krenek, Andrea, Courville, Amber, Yang, Shanna, Turner, Sara A, Meyers, Abby G, Estrada, Doris E, Yadav, Hariom, Chung, Stephanie T

“…Dr. Yadav is Chief Scientific Officer and Co-Founder of Postbiotics Inc and has no conflict of interest with this work. All other authors have no conflicts of…”
Get full text

1326-P: Metformin Increases GLP-1 Concentrations and Improves Glycemia in Youth with Type 2 Diabetes by CRAVALHO, CELESTE K., MEYERS, ABBY G., MABUNDO, LILIAN, COURVILLE, AMBER B., BERNSTEIN, SHANNA, DAI, YUHAI, WALTER, MARY, CHACKO, SHAJI, HAYMOND, MOREY W., CHUNG, STEPHANIE T.

“…Metformin is the only approved oral agent for youth with type 2 diabetes (T2D), but its mechanism of action remains controversial. Recent data suggests a…”
Get full text

Determinants of health after hospital discharge: rationale and design of the Vanderbilt Inpatient Cohort Study (VICS) by Meyers, Abby G, Salanitro, Amanda, Wallston, Kenneth A, Cawthon, Courtney, Vasilevskis, Eduard E, Goggins, Kathryn M, Davis, Corinne M, Rothman, Russell L, Castel, Liana D, Donato, Katharine M, Schnelle, John F, Bell, Susan P, Schildcrout, Jonathan S, Osborn, Chandra Y, Harrell, Frank E, Kripalani, Sunil

“…The period following hospital discharge is a vulnerable time for patients when errors and poorly coordinated care are common. Suboptimal care transitions for…”
Get full text

Metformin treatment and gastrointestinal symptoms in youth: Findings from a large tertiary care referral center by Meyers, Abby G., Hudson, Jennifer, Cravalho, Celeste K. L., Matta, Samantha T., Villalobos‐Perez, Alfredo, Cogen, Fran, Chung, Stephanie T.

“…Objectives Metformin is the only oral therapy for youth with type 2 diabetes, but up to 50% require additional agents within 2 years of diagnosis…”
Get full text

Nuclear Magnetic Resonance Derived Biomarkers for Evaluating Cardiometabolic Risk in Youth and Young Adults Across the Spectrum of Glucose Tolerance by Chung, Stephanie T, Matta, Samantha T, Meyers, Abby G, Cravalho, Celeste K, Villalobos-Perez, Alfredo, Dawson, Joshua M, Sharma, Vandhna R, Sampson, Maureen L, Otvos, James D, Magge, Sheela N

“…Youth with obesity have an increased risk for cardiometabolic disease, but identifying those at highest risk remains a challenge. Four biomarkers that might…”
Get full text

1160-P: Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes-Interim Results from Pilot Randomized Controlled 12-Week Trial by Patel, Tejal, Estrada, Doris E, Meyers, Abby, Mackey, Eleanor, Chung, Stephanie T

“…Introduction: Continuous glucose monitors (CGM) may improve diabetes self-management in youth-onset type 2 diabetes (Y-T2D), but feasibility in Y-T2D on…”
Get full text

Increase in the Diagnosis and Severity of Presentation of Pediatric Type 1 and Type 2 Diabetes during the COVID-19 Pandemic by Marks, Brynn E, Khilnani, Aneka, Meyers, Abby, Flokas, Myrto E, Gai, Jiaxiang, Monaghan, Maureen, Streisand, Randi, Estrada, Elizabeth

“…The impact of the COVID-19 pandemic on the incidence of pediatric type 1 (T1D) and type 2 diabetes (T2D) and severity of presentation at diagnosis is unclear…”
Get more information

15-OR: The COVID-19 Pandemic and New-Onset Pediatric Type 2 Diabetes by MARKS, BRYNN E., KHILNANI, ANEKA, MEYERS, ABBY, ESTRADA, DORIS E., BOUGHTON, JENNIFER, GAI, JIAXIANG, STREISAND, RANDI, MONAGHAN, MAUREEN

“…Introduction: Reports are emerging about the impact of the COVID-19 pandemic on pediatric T1D, however few studies have explored pediatric T2D. We aimed to…”
Get full text

Prebiotics and Metformin: A Pilot Randomized Controlled Trial in Youth-Onset Type 2 Diabetes by Dixon, Sydney, Mishra, Sidharth, Jain, Shalini, Meyers, Abby, Mabundo, Lilian, Stagliano, Michael, Villalobos-Perez, Alfredo, Bethesda, Katrina Dietsche, Courville, Amber, Bethesda, R D N, Auh, Sungyoung, Estrada, Doris, Yadav, Hariom, Chung, Stephanie

Get full text

990-P: Prebiotics and Metformin: A Pilot Randomized Controlled Trial in Youth-Onset Type 2 Diabetes by DIXON, SYDNEY A., MEYERS, ABBY, TUTTLE, KUNANI, MABUNDO, LILIAN, STAGLIANO, MICHAEL S., VILLALOBOS-PEREZ, ALFREDO, DIETSCHE, KATRINA B., COURVILLE, AMBER B., ESTRADA, DORIS E., CHUNG, STEPHANIE T.

“…Metformin is the only first-line oral agent for youth with type 2 diabetes mellitus (Y-T2D) , but efficacy and adherence is complicated by gastrointestinal…”
Get full text

991-P: Metformin Plasma Concentration as a Biomarker of Treatment Responsiveness in Youth-Onset Type 2 Diabetes by DIETSCHE, KATRINA B., ZENNO, ANNA, VILLALOBOS-PEREZ, ALFREDO, DIXON, SYDNEY A., STAGLIANO, MICHAEL S., MABUNDO, LILIAN, SHOUPPE, EILEEN L., ESTRADA, DORIS E., MEYERS, ABBY, COGEN, FRAN R., WALTER, MARY, WALTER, PETER, CHUNG, STEPHANIE T.

“…Metformin is the first-line therapy for youth-onset type 2 diabetes mellitus (Y-T2D) but is suboptimal in up to 50% of youth. The reasons for increased failure…”
Get full text

1259-P: Dyslipidemia of Insulin Resistance Is Associated with Subclinical Inflammation in Youth with Type 2 Diabetes by VILLALOBOS-PEREZ, ALFREDO, CRAVALHO, CELESTE K., MATTA, SAMANTHA, MEYERS, ABBY, MABUNDO, LILIAN, SAMPSON, MAUREEN L., WALTER, MARY, COURVILLE, AMBER B., CHUNG, STEPHANIE T.

“…The dyslipidemia of insulin resistance (IR), characterized by high triglyceride-rich lipoproteins (TRLP) and low high-density lipoproteins (HDL), is associated…”
Get full text

1934-P: Branched-Chain Amino Acids Are Poor Markers of Insulin Resistance in Women: The Federal Women’s Study by MATTA, SAMANTHA, CRAVALHO, CELESTE K., VILLALOBOS-PEREZ, ALFREDO, MEYERS, ABBY, MABUNDO, LILIAN, COURVILLE, AMBER B., SAMPSON, MAUREEN L., SUMNER, ANNE E., CHUNG, STEPHANIE T.

“…The data relating branched chain amino acids (BCAAs) with obesity and type 2 diabetes is conflicting but may be further clarified by examining its relationship…”
Get full text

1275-P: Higher Branched-Chain Amino Acids in Youth with Type 2 Diabetes Paradoxically Increased by Short-Term Metformin by MEYERS, ABBY, CRAVALHO, CELESTE K., VILLALOBOS-PEREZ, ALFREDO, MATTA, SAMANTHA, MABUNDO, LILIAN, COURVILLE, AMBER B., SAMPSON, MAUREEN L., OTVOS, JAMES D., CHUNG, STEPHANIE T.

“…Branched chain amino acids (BCAA) are important signaling molecules that are strongly related to type 2 diabetes (T2D), but the data linking BCAAs to reduced…”
Get full text

1243-P: NMR-Derived Biomarkers Identify Cardiometabolic Disease Risk in Youth by CHUNG, STEPHANIE T., MATTA, SAMANTHA, MEYERS, ABBY, CRAVALHO, CELESTE K., VILLALOBOS-PEREZ, ALFREDO, MABUNDO, LILIAN, COURVILLE, AMBER B., SAMPSON, MAUREEN L., OTVOS, JAMES D., MAGGE, SHEELA N.

“…Youth with obesity have increased risk for cardiometabolic (CM) disease but identifying those at highest risk remains a challenge. 4 potential biomarkers are…”
Get full text